evaluation of safety and efficacy of therapeutic angiogenesis by low-energy extracorporeal shock wave to peripheral arterial disease

evaluation of safety and efficacy of therapeutic angiogenesis by low-energy extracorporeal shock wave to peripheral arterial disease - evaluation of safety and efficacy of low-energy extracorporeal shock wave therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004265

Enrollment

Registered

2010-09-27

Start date

2009-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral arterial disease

Interventions

extracorporeal shock wave

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients with peripheral artery disease more than Fontaine stage 2

Exclusion criteria

Exclusion criteria: The patients can not agree with this study

Design outcomes

Primary

Measure	Time frame
adverse event	—

Secondary

Measure	Time frame
tissue blood flow	—

Countries

Japan

Contacts

Public ContactManabu Uwajima

Nippon Medical School General affairs

youdo@nms.ac.jp03-3822-2131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026